Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Helix Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Helix Therapeutics

Helix Therapeutics

Inactive

Helix Therapeutics Inc. pioneers in DNA-based therapies for HIV/AIDS, sickle cell anemia, and cystic fibrosis in the US.

HQ
New Haven, CT, US
Founded
2006
Overview
Compare
Fundraising
Employees
Website

Helix Therapeutics Inc. was founded with the mission to revolutionize the treatment of genetic disorders through DNA-based therapeutics. The company's vision is to provide innovative, sequence-specific gene-targeting treatments for diseases such as HIV/AIDS, sickle cell anemia, and cystic fibrosis. Helix Therapeutics focuses on serving patients and healthcare providers in the United States by developing cutting-edge therapies that address the root causes of these conditions.

Notable figures affiliated with Helix Therapeutics include leading researchers and scientists in the field of genetic therapy. The company has attracted significant investment from venture capital firms specializing in biotech innovations. Key achievements include successful preclinical trials demonstrating the efficacy of their gene-targeting treatments. Overall, Helix Therapeutics has made a substantial impact by advancing the potential for curative therapies for chronic genetic diseases, aiming to improve patient outcomes and quality of life.

Helix Therapeutics - Similar Companies

Helix BioMedix logo

Helix BioMedix

helixbiomedix.com

Helicon Therapeutics logo

Helicon Therapeutics

Helixbind logo

Helixbind

helixbind.com

Helex logo

Helex

helex.bio

Helixomer logo

Helixomer

helixomer.com

Helix Nanotechnologies logo

Helix Nanotechnologies

helixnano.com

Excision BioTherapeutics logo

Excision BioTherapeutics

Gene Sciences logo

Gene Sciences

Heligenics logo

Heligenics

heligenics.com

Dnalite Therapeutics logo

Dnalite Therapeutics

Golden Helix logo

Golden Helix

goldenhelix.com

Spiral Therapeutics logo

Spiral Therapeutics

spiraltx.com

Halia Therapeutics logo

Halia Therapeutics

Lapix Therapeutics logo

Lapix Therapeutics

lapix.com

GlyGenix Therapeutics logo

GlyGenix Therapeutics

Helix Therapeutics - Quick Facts

Who are Helix Therapeutics' competitors?

Companies similar to Helix Therapeutics include Helix BioMedix, Helicon Therapeutics, Helixbind and Helex.

When was Helix Therapeutics founded?

Helix Therapeutics was founded in 2006.

Where is Helix Therapeutics' headquarters located?

Helix Therapeutics' headquarters is located in New Haven, CT, US.

When was Helix Therapeutics' last funding round?

Helix Therapeutics' most recent funding round was for $2.5M (USD) in November 2010.

How much has Helix Therapeutics raised to-date?

As of Nov 23, 2010, Helix Therapeutics has raised a total of $3.4M (USD).

Helix Therapeutics - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Main Product
  • DNA Therapies
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified